Abstract
Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(−)-EGCG]. Use of PRO-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications.
| Original language | English |
|---|---|
| Patent number | US 10646467 |
| IPC | A61K31/353 |
| Priority date | 20/08/12 |
| Filing date | 28/01/19 |
| Publication status | Published - 12 May 2020 |